Apr 14, 2022
7 min read
First Long-Covid Treatment (ADAPT-232/Chisan) Shows Promise in Randomized Clinical Trial
But the effect size is not that great.
Given the annoyingly diverse faces of long-Covid, otherwise known as the post-Covid syndrome, a magical cure is near-impossible.
Even so, not all hope is lost, as a recent randomized clinical trial from Georgia and Sweden has…
